1.
Med (N Y)
; 3(8): 531-537, 2022 08 12.
Artículo
en Inglés
| MEDLINE | ID: covidwho-1983656
RESUMEN
The protection provided by natural versus hybrid immunity from COVID-19 is unclear. We reflect on the challenges from trying to conduct a randomized post-SARS-CoV-2 infection vaccination trial study with rapidly evolving scientific data, vaccination guidelines, varying international policies, difficulties with vaccine availability, vaccine hesitancy, and a constantly evolving virus.